IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Durata Therapeutics Ixpn

CUSIP: 266CVR901 | 4 institutional holders

Quarters

Q1 2015Q4 2014
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q1 2015

Summit Securities Group LLC5,400
0.0% of portfolio›$0
StyleTurnoverLocationFiled
Summit Securities Group LLC
5,400$00.0%GARPVery HighNew York, NY2015-04-22